Comprehensive Evaluation of a Novel Nuclear Factor-κB Inhibitor, Quinoclamine, by Transcriptomic Analysis
British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.2009.00223.x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2009
Authors
Publisher
Wiley